EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glucose‐Operated Widget (GLOW) for Closed‐Loop Optogenetic Glycemic Control

Debasis Maity, Preetam Guha Ray iD, Martin Fussenegger iD

Advanced Materials · 2024

DOI: 10.1002/adma.202408537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Debasis Maity und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Klingelbergstrasse 48, Basel, CH-4056, Switzerland. Hauptthemen laut MEDLINE: Optogenetics, Glucose, Insulin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HORIZON EUROPE Framework Programme, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, H2020 European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Closed‐loop control systems for precise control of therapeutic gene expression are promising candidates for personalized treatment of chronic ailments such as diabetes. Pancreatic iβ‐cells are engineered with blue‐light‐inducible melanopsin to drive rapid insulin release by vesicular secretion from intracellular stores. In this work, a glucose‐operated widget (GLOW) is designed as a component of a closed‐loop control system for diabetes treatment by employing a probe that emits blue fluorescence in a glucose‐concentration‐dependent manner as a real‐time glucose sensor to precisely control insulin release from these iβ‐cells. As proof‐of‐concept of the complete control system, the probe is encapsulated together with iβ‐cells in alginate‐poly‐(L‐lysine) hydrogel‐microbeads(400 µm in diameter and containing about 500 cells) called GLOW iβ (GLOW with iβ‐cells), are subcutaneously implanted into type‐1‐diabetic (T1D) mice. Illumination by UV‐A light at 390 nm results in glucose‐concentration‐dependent blue‐light emission from the probe at 445 nm that in turn induces glucose‐concentration‐dependent insulin release from the iβ‐cells in a fully reversible manner. Activation of the injected GLOW iβ at 390 nm for 15 min effectively restores normoglycemia within 60–120 min in a closed‐loop manner in these diabetic mice. The system is robust, as normoglycemia is well maintained by daily activation for at least 7 days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OptogeneticsGlucoseInsulinAnimalsMiceInsulin-Secreting CellsGlycemic ControlDiabetes Mellitus, Type 1HydrogelsDiabetes Mellitus, ExperimentalBlood GlucosePolylysineAlginatesInsulin Secretion

Stichwörter der Autor:innen

beta cellsclosed‐loopinsulinsynthetic biologytype‐1 diabetes

Substanzen

GlucoseInsulinHydrogelsBlood GlucosePolylysineAlginates

Autor:innen und Institutionen

  • Department of Biosystems Science and Engineering, ETH Zurich, Klingelbergstrasse 48, Basel, CH-4056, Switzerland.
  • Faculty of Science, University of Basel, Klingelbergstrasse 48, Basel, CH-4056, Switzerland.

ORCID-Profile: Preetam Guha Ray, Martin Fussenegger

Förderung

  • HORIZON EUROPE Framework Programme
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • H2020 European Research Council

Zitieren

APA

Maity, D., Guha Ray, P., & Fussenegger, M. (2024). Glucose‐Operated Widget (GLOW) for Closed‐Loop Optogenetic Glycemic Control. Advanced Materials. https://doi.org/10.1002/adma.202408537

Vancouver

Maity D, Guha Ray P, Fussenegger M. Glucose‐Operated Widget (GLOW) for Closed‐Loop Optogenetic Glycemic Control. Advanced Materials. 2024. doi:10.1002/adma.202408537

BibTeX
@article{Maity2024,
  author = {Maity, Debasis and Guha Ray, Preetam and Fussenegger, Martin},
  title = {Glucose‐Operated Widget (GLOW) for Closed‐Loop Optogenetic Glycemic Control},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202408537}
}
Kostenlos starten →